Blincyto União Europeia - português - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - leucemia linfoblástica com células precursoras - linfoma - agentes antineoplásicos - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Incivo União Europeia - português - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatite c, crônica - antivirais para uso sistêmico - incivo, em combinação com o interferão alfa e ribavirina, é indicado para o tratamento do genótipo-1 hepatite crônica c em pacientes adultos com doença hepática compensada (incluindo cirrose):quem é o tratamento ingênuo;que tenham sido previamente tratados com interferon alfa (peguilado ou não-peguilado) em monoterapia ou em combinação com ribavirina, incluindo relapsers, parcial respondentes e nulo respondentes.

Vectormune FP ILT + AE União Europeia - português - EMA (European Medicines Agency)

vectormune fp ilt + ae

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - frango - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Ultifend ND IBD União Europeia - português - EMA (European Medicines Agency)

ultifend nd ibd

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologias para aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Vectormune FP ILT União Europeia - português - EMA (European Medicines Agency)

vectormune fp ilt

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - frango - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Paracetamol Unither Pharmaceuticals 500 mg/5 ml Solução oral em saqueta Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

paracetamol unither pharmaceuticals 500 mg/5 ml solução oral em saqueta

unither pharmaceuticals sas - paracetamol - solução oral em saqueta - 500 mg/5 ml - paracetamol 500 mg - paracetamol - n/a - duração do tratamento: curta ou média duração

Paracetamol Unither Pharmaceuticals 1000 mg/10 ml Solução oral em saqueta Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

paracetamol unither pharmaceuticals 1000 mg/10 ml solução oral em saqueta

unither pharmaceuticals sas - paracetamol - solução oral em saqueta - 1000 mg/10 ml - paracetamol 1000 mg - paracetamol - n/a - duração do tratamento: curta ou média duração

Incurin União Europeia - português - EMA (European Medicines Agency)

incurin

intervet international bv - estriol - hormônios sexuais e moduladores do sistema genital - cães - o tratamento da incontinência urinária dependente de hormônio devido à incompetência do mecanismo do esfíncter em cadelas ovarrectomizadas.

CO-PRESSOTEC Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

co-pressotec

laboratÓrio teuto brasileiro s/a - maleato de enalapril, hidroclorotiazida - anti-hipertensivos

Co-Diovan 80 mg + 12.5 mg Comprimido revestido por película Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

co-diovan 80 mg + 12.5 mg comprimido revestido por película

novartis farma - produtos farmacêuticos, s.a. - valsartan + hidroclorotiazida - comprimido revestido por película - 80 mg + 12.5 mg - valsartan 80 mg ; hidroclorotiazida 12.5 mg - valsartan and diuretics - n/a - duração do tratamento: longa duração